Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest pharmaceutical industry Stories

2014-04-21 12:26:38

MUMBAI, India and BALTIMORE, April 21, 2014 /PRNewswire/ -- Pharma major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. Theresa will assume full responsibility for global merger and acquisitions and specialty business strategy. Prior to joining Lupin, Theresa was with Aptalis pharma as the Chief Corporate Development Officer responsible for Mergers & Acquisitions (M&A), Strategy and Global...

2014-04-21 12:25:01

Drug Prices are to Remain High in Vietnam, Due to Limited Domestic Drug Production and a Lack of Cost-Containment Measures, According to Findings from Decision Resources Group BURLINGTON, Mass., April 21, 2014 /PRNewswire/ -- Decision Resources Group finds that Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a growth rate of nearly 17 percent and exceeding $3 billion in size in 2013. Increasing affluence, a rapidly aging population and the...

2014-04-20 23:01:49

Huge amount of damages awarded to New York man who was diagnosed with bladder cancer that jurors were told was caused by diabetes drug Actos. National network of attorneys continues offer of no-cost consultations to consumers seeking compensation over similar claims. San Diego, CA (PRWEB) April 20, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced that it is providing consumers who may have been affected by Actos...

2014-04-19 23:00:42

ReportsnReports.com adds the latest report on “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014” to its store. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=279869. Dallas, TX (PRWEB) April 19, 2014 This report provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the trial...

2014-04-18 23:08:24

OMICS Group announces the 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit during Sep 29 - Oct 01, 2014 at Baltimore, USA with the theme “Innovative Approaches of BABE to Revolutionize the Next Generation Medicine” Los Angeles, CA (PRWEB) April 18, 2014 BABE-2014 is all set to explore the innovations, advancements in the field of pharmaceutical industry, which shows significant impact on the development of new and improved generic drugs. These...

2014-04-18 23:04:22

Markets Research Reports.biz added deep and professional market research reports on "HIV Therapeutics Market To 2019" Industry Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis/193009 (PRWEB) April 18, 2014 The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress...

2014-04-18 23:04:04

Panel at DIA Annual Meeting to Explore Leveraging Data and Analytics to Enhance Collaboration Washington (PRWEB) April 18, 2014 The impact of “big data” on the partnerships between contract research organizations (CROs) and clinical trial sponsors will be discussed at the DIA 2014 50th Annual Meeting, June 15 to 19, in San Diego. The “Big Data, Big Impact: New Levels of Strategic Partnerships Between Sponsors-CROs” forum, held on June 17 at 8 a.m. in the San Diego Convention...

2014-04-18 20:20:48

CHAPEL HILL, N.C., April 18, 2014 /PRNewswire/ -- Medical Device organizations are increasingly being challenged to deliver exceptional services to a diverse set of customers and stakeholders. On top of this, concerns about compliance and legal limitations are forcing companies to re-examine how their medical science liaisons (MSLs) and internal medical staff are working to build relationships with key customer groups and decision-makers. Given the expanding role of MSLs, it's critical for...

2014-04-18 08:22:04

PARSIPPANY, N.J., April 18, 2014 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that Ken Keller will join the company as President of its Commercial operations in the United States starting May 1, 2014. In his role, Mr. Keller will be responsible for leading marketing, sales, medical affairs and supply chain operations for Daiichi Sankyo in the U.S. "We are very pleased to welcome Ken Keller into the Daiichi Sankyo family," said Joji Nakayama, President and CEO of Daiichi...

2014-04-18 04:20:58

DUBLIN, April 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ddkpws/mice_model_market) has announced the addition of the "Mice Model Market - by Type, Technology, Disease, Service & Care Products - Forecasts to 2018" [http://www.researchandmarkets.com/research/ddkpws/mice_model_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Over the years, the use of mice models has...